BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Aging
    • Biosimilars
    • Artificial intelligence
    • Coronavirus
    • IVDs on the rise
    • Radiopharmaceuticals
    • Science '22 in Review
    • Top Biopharma Trends of 2022
    • Top Med-tech Trends of 2022
    • Premium reports
      • BioWorld Financings Reports
      • Disease Incidence & Prevalence Summaries

BioWorld. Link to homepage.

  • sign in
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, September 22, 2023

Orthopedics

Home » Topics » Disease categories and therapies » Orthopedics
  • Grey dollar sign on grey background
    Sep. 19, 2023
    By Annette Boyle

    Boston Scientific to acquire Relievant Medsystems in $850M+ deal

    Before the Wall Street opening bell on Tuesday, Boston Scientific Corp. reported plans to acquire privately held Relievant Medsystems Inc. for $850 million in cash at closing plus undisclosed payments contingent on sales performance of the company’s lead product, the Intracept intraosseous nerve ablation system, over the next three years.
  • Deal merger acquisition cancel terminate
    Sep. 13, 2023
    By Annette Boyle

    Quite a fix: Orthofix sacks three top execs

    Orthofix Medical Inc. terminated its CEO, chief financial officer and chief legal officer in a move that plunged the stock from $18.63 at Monday’s close to $13.01 by the end of Tuesday. The clean sweep of the executive suite followed the “unanimous decision by the board’s independent directors to terminate for cause Keith Valentine, John Bostjancic and Patrick Keran,” the company said in a statement that named their interim replacements. Valentine was also asked to resign from the board.
  • Novastep
    Aug. 8, 2023
    By Bernard Banga

    Novastep acquisition puts Enovis on firm footing

    Enovis Corp. acquired Novastep SAS and its foot and ankle minimally invasive surgical (MIS) platform from Amplitude Surgical SAS for €68 million.
Read More

Blog Posts

  • April 14, 2015
    By Omar Ford

    SGR specter haunts AAOS 2015 conference

  • May 29, 2014
    By Holland Johnson

    Stryker S&N acquisition rumors bolster recent orthopedic space consolidation

  • May 15, 2014
    By Amanda Pedersen

    Enough stinky greens, med-tech wants dessert!

  • Nov. 20, 2013
    By Robert Kimball

    Sundays with Peyton now not a pain in the neck

  • Thca3y7qli
    March 13, 2013
    By Jim Stommen

    Gigantic jury award in first J&J hip implant case is breathtaking as an initial benchmark

Read More

Authors

  • Holland Johnson
  • Omar Ford
  • Amanda Pedersen
  • Jim Stommen
  • Robert Kimball
  • Liz Hollis
More Authors
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
Follow Us

Copyright ©2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing